drugset / Trial / NCT00576381
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine what happens to dexmedetomidine in the body after it has been given to a newborn after heart surgery. We want to learn how long the drug stays in the body, how the drug is metabolized by the body, and how well the medicine works at a particular dose or amount.
Timeline
- Start
- 2006-04
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 0.3 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | — |